Study Stopped
IRB closed due to slow accrual
Balloon Dilation Methods for Benign Esophageal Stricture
Randomized Prospective Trial of Balloon Dilation Technique for Benign Esophageal Strictures.
1 other identifier
interventional
N/A
1 country
1
Brief Summary
This is the first head to head, prospective, randomized, double-blind clinical trial comparing two different approaches of balloon dilation (standard versus progressive dilation) for benign esophageal strictures. A retrospective study on patients with benign esophageal strictures that underwent balloon dilation using the proposed technique found considerable symptomatic improvement in dysphagia. The proposed balloon dilation method is a novel approach that will require fewer sessions of dilation and use fewer balloon dilation catheters to achieve a maximum balloon diameter of 18mm and result in a significant symptomatic improvement.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jul 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 13, 2020
CompletedFirst Submitted
Initial submission to the registry
January 25, 2021
CompletedFirst Posted
Study publicly available on registry
January 29, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2022
CompletedNovember 23, 2022
November 1, 2022
2.1 years
January 25, 2021
November 18, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Change in Dysphagia
Dysphagia will be measured using a 10-pt Likert scale in response to the question "In the last 7 days how would you rate the severity of your trouble swallowing." Lower scores indicate less difficulty swallowing.
1 year (at 1, 3, 6 and 12 months follow-up)
Number of endoscopic dilation sessions
The number of endoscopic dilation sessions needed to achieve clinical success as defined by endoscopic and clinical resolution of dysphagia symptoms.
3 weeks
Number of balloons
The number of balloons needed to achieve clinical success as defined by endoscopic and clinical resolution of dysphagia symptoms.
3 weeks
Study Arms (2)
Standard Balloon Dilation
ACTIVE COMPARATORPatients in this group will receive standard balloon dilation therapy.
Progressive Balloon Dilation
EXPERIMENTALPatients in this group will receive progressive balloon dilation therapy.
Interventions
The standard approach involves a gradual balloon dilation where the balloon is inflated then held at each balloon size for 30-60 seconds then inflated to the next largest balloon diameter size and repeated to the maximum diameter size of that catheter. The dilation session will be repeated as frequently and as many times as needed to achieve the balloon diameter size of 18mm at the discretion of the endoscopist.
In the progressive approach, the balloon is continuously inflated over the course of 3-5 minutes starting at the smallest to the largest balloon diameter depending of the balloon catheter used. The dilation will be repeated every 2-3 weeks (total of 2-3 sessions). At the next endoscopic procedure, the balloon diameter used will be the next size up based on previous session.
Eligibility Criteria
You may qualify if:
- more than 18 years old
- symptoms of dysphagia (difficulty swallowing) due to a benign esophageal stricture
- willing to be randomized to either arm of the study.
You may not qualify if:
- less than 18 years of age
- malignant esophageal stricture
- stricture located in the gastrointestinal tract other than the esophagus
- any benign or malignant stricture regardless of location in which the patient had previous mechanical or balloon dilation
- diagnosis of achalasia
- currently pregnant
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Samuel H Mardinilead
Study Sites (1)
University of Kentucky
Lexington, Kentucky, 40536, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Samuel H Mardini, MD
University of Kentucky
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
January 25, 2021
First Posted
January 29, 2021
Study Start
July 13, 2020
Primary Completion
September 1, 2022
Study Completion
September 1, 2022
Last Updated
November 23, 2022
Record last verified: 2022-11
Data Sharing
- IPD Sharing
- Will not share